Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome

Felicita Andreotti, Eliano Pio Navarese, Volker Schulze, Mariusz Kowalewski, Michalina Kołodziejczak, David E. Kandzari, Tienush Rassaf, Maximilian Brockmeyer, Christian Meyer, Sergio Berti, Jacek Kubica, Malte Kelm, Marco Valgimigli

Risultato della ricerca: Contributo in rivistaArticolo in rivista

56 Citazioni (Scopus)

Abstract

The aim of this meta-analysis was to compare the 30-day safety and efficacy of bivalirudin with those of heparin with or without routine administration of a glycoprotein IIb/IIIa inhibitor (GPI) in patients with acute coronary syndrome (ACS).
Lingua originaleEnglish
pagine (da-a)201-213
Numero di pagine13
RivistaJACC: Cardiovascular Interventions
Volume8
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • GP IIb/IIIa inhibitor
  • acute coronary syndrome
  • bivalirudin
  • heparin
  • meta-analysis

Fingerprint

Entra nei temi di ricerca di 'Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome'. Insieme formano una fingerprint unica.

Cita questo